サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1732621

アルツハイマー病治療薬の世界市場 2025～2029年

Global Alzheimers Disease Therapeutics Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 225 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
アルツハイマー病治療薬の世界市場 2025～2029年
出版日: 2025年05月17日
発行: TechNavio
ページ情報: 英文 225 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アルツハイマー病治療薬市場は2024-2029年に59億8,020万米ドル、予測期間中のCAGRは10.2％で成長すると予測されます。

当レポートでは、アルツハイマー病治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、新規バイオマーカーの入手可能性、研究開発、アルツハイマー病に対する認識の高まり、治療薬の承認と強力なパイプラインによって牽引されています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 9.2%
CAGR 10.2%
増分額 59億8,020万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間のアルツハイマー病治療薬市場の成長を促進する主な理由の一つとして、再生療法の出現を挙げています。また、治療薬発見のための資金調達の増加や高感度診断モダリティの利用可能性は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024-2029

第5章 市場規模実績

  • アルツハイマー病治療薬の世界市場 2019-2023
  • 流通チャネル別セグメント分析 2019-2023
  • 薬剤クラス別セグメント分析 2019-2023
  • 治療領域別セグメント分析 2019-2023
  • 地域別セグメント分析 2019-2023
  • 国別セグメント分析 2019-2023

第6章 定性分析

  • AIの影響：アルツハイマー病治療薬の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：流通チャネル別

  • 市場セグメント
  • 比較：流通チャネル別
  • 病院薬局：市場規模と予測 2024-2029
  • 小売薬局：市場規模と予測 2024-2029
  • Eコマース薬局：市場規模と予測 2024-2029
  • 市場機会：流通チャネル別

第9章 市場セグメンテーション：薬剤クラス別

  • 市場セグメント
  • 比較：薬剤クラス別
  • コリンエステラーゼ阻害剤：市場規模と予測 2024-2029
  • N-メチル-D-アスパラギン酸受容体拮抗薬：市場規模と予測 2024-2029
  • その他：市場規模と予測 2024-2029
  • 市場機会：薬剤クラス別

第10章 市場セグメンテーション：治療領域別

  • 市場セグメント
  • 比較：治療領域別
  • 対症療法：市場規模と予測 2024-2029
  • 疾患修飾療法：市場規模と予測 2024-2029
  • 免疫療法：市場規模と予測 2024-2029
  • 遺伝子治療：市場規模と予測 2024-2029
  • 低分子阻害剤：市場規模と予測 2024-2029
  • 市場機会：治療領域別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024-2029
  • 欧州：市場規模と予測 2024-2029
  • アジア：市場規模と予測 2024-2029
  • 世界のその他の地域：市場規模と予測 2024-2029
  • 米国：市場規模と予測 2024-2029
  • カナダ：市場規模と予測 2024-2029
  • 英国：市場規模と予測 2024-2029
  • ドイツ：市場規模と予測 2024-2029
  • 日本：市場規模と予測 2024-2029
  • 中国：市場規模と予測 2024-2029
  • フランス：市場規模と予測 2024-2029
  • メキシコ：市場規模と予測 2024-2029
  • インド：市場規模と予測 2024-2029
  • ブラジル：市場規模と予測 2024-2029
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • AB Science SA
  • AbbVie Inc.
  • AgeneBio Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Inc.
  • Eisai Co. Ltd.
  • Eli Lilly and Co.
  • Grifols SA
  • H Lundbeck AS
  • Johnson and Johnson
  • Lupin Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Solco Healthcare
  • Teva Pharmaceutical Industries Ltd.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Alzheimers Disease Therapeutics Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Distribution Channel - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Distribution Channel - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Distribution Channel
  • Exhibits41: Data Table on Comparison by Distribution Channel
  • Exhibits42: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on E-commerce pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on E-commerce pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on E-commerce pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on E-commerce pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Market opportunity by Distribution Channel ($ million)
  • Exhibits55: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits56: Chart on Drug Class - Market share 2024-2029 (%)
  • Exhibits57: Data Table on Drug Class - Market share 2024-2029 (%)
  • Exhibits58: Chart on Comparison by Drug Class
  • Exhibits59: Data Table on Comparison by Drug Class
  • Exhibits60: Chart on Cholinesterase inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Cholinesterase inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Cholinesterase inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Cholinesterase inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Market opportunity by Drug Class ($ million)
  • Exhibits73: Data Table on Market opportunity by Drug Class ($ million)
  • Exhibits74: Chart on Therapeutic Area - Market share 2024-2029 (%)
  • Exhibits75: Data Table on Therapeutic Area - Market share 2024-2029 (%)
  • Exhibits76: Chart on Comparison by Therapeutic Area
  • Exhibits77: Data Table on Comparison by Therapeutic Area
  • Exhibits78: Chart on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Chart on Disease-modifying therapies - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Disease-modifying therapies - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Disease-modifying therapies - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Disease-modifying therapies - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Immunotherapies - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Immunotherapies - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Immunotherapies - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Immunotherapies - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Chart on Gene therapies - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Data Table on Gene therapies - Market size and forecast 2024-2029 ($ million)
  • Exhibits92: Chart on Gene therapies - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Data Table on Gene therapies - Year-over-year growth 2024-2029 (%)
  • Exhibits94: Chart on Small molecule inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Data Table on Small molecule inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits96: Chart on Small molecule inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Data Table on Small molecule inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits98: Market opportunity by Therapeutic Area ($ million)
  • Exhibits99: Data Table on Market opportunity by Therapeutic Area ($ million)
  • Exhibits100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits101: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits103: Chart on Geographic comparison
  • Exhibits104: Data Table on Geographic comparison
  • Exhibits105: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Mexico - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits158: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits159: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits160: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits161: Market opportunity By Geographical Landscape ($ million)
  • Exhibits162: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits163: Impact of drivers and challenges in 2024 and 2029
  • Exhibits164: Overview on criticality of inputs and factors of differentiation
  • Exhibits165: Overview on factors of disruption
  • Exhibits166: Impact of key risks on business
  • Exhibits167: Companies covered
  • Exhibits168: Company ranking index
  • Exhibits169: Matrix on companies position and classification
  • Exhibits170: AB Science SA - Overview
  • Exhibits171: AB Science SA - Product / Service
  • Exhibits172: AB Science SA - Key offerings
  • Exhibits173: SWOT
  • Exhibits174: AbbVie Inc. - Overview
  • Exhibits175: AbbVie Inc. - Product / Service
  • Exhibits176: AbbVie Inc. - Key news
  • Exhibits177: AbbVie Inc. - Key offerings
  • Exhibits178: SWOT
  • Exhibits179: AgeneBio Inc. - Overview
  • Exhibits180: AgeneBio Inc. - Product / Service
  • Exhibits181: AgeneBio Inc. - Key offerings
  • Exhibits182: SWOT
  • Exhibits183: Aurobindo Pharma Ltd. - Overview
  • Exhibits184: Aurobindo Pharma Ltd. - Product / Service
  • Exhibits185: Aurobindo Pharma Ltd. - Key offerings
  • Exhibits186: SWOT
  • Exhibits187: Cipla Inc. - Overview
  • Exhibits188: Cipla Inc. - Business segments
  • Exhibits189: Cipla Inc. - Key news
  • Exhibits190: Cipla Inc. - Key offerings
  • Exhibits191: Cipla Inc. - Segment focus
  • Exhibits192: SWOT
  • Exhibits193: Eisai Co. Ltd. - Overview
  • Exhibits194: Eisai Co. Ltd. - Business segments
  • Exhibits195: Eisai Co. Ltd. - Key offerings
  • Exhibits196: Eisai Co. Ltd. - Segment focus
  • Exhibits197: SWOT
  • Exhibits198: Eli Lilly and Co. - Overview
  • Exhibits199: Eli Lilly and Co. - Product / Service
  • Exhibits200: Eli Lilly and Co. - Key offerings
  • Exhibits201: SWOT
  • Exhibits202: Grifols SA - Overview
  • Exhibits203: Grifols SA - Business segments
  • Exhibits204: Grifols SA - Key news
  • Exhibits205: Grifols SA - Key offerings
  • Exhibits206: Grifols SA - Segment focus
  • Exhibits207: SWOT
  • Exhibits208: H Lundbeck AS - Overview
  • Exhibits209: H Lundbeck AS - Product / Service
  • Exhibits210: H Lundbeck AS - Key offerings
  • Exhibits211: SWOT
  • Exhibits212: Johnson and Johnson - Overview
  • Exhibits213: Johnson and Johnson - Business segments
  • Exhibits214: Johnson and Johnson - Key news
  • Exhibits215: Johnson and Johnson - Key offerings
  • Exhibits216: Johnson and Johnson - Segment focus
  • Exhibits217: SWOT
  • Exhibits218: Lupin Ltd. - Overview
  • Exhibits219: Lupin Ltd. - Business segments
  • Exhibits220: Lupin Ltd. - Key news
  • Exhibits221: Lupin Ltd. - Key offerings
  • Exhibits222: Lupin Ltd. - Segment focus
  • Exhibits223: SWOT
  • Exhibits224: Novartis AG - Overview
  • Exhibits225: Novartis AG - Business segments
  • Exhibits226: Novartis AG - Key news
  • Exhibits227: Novartis AG - Key offerings
  • Exhibits228: Novartis AG - Segment focus
  • Exhibits229: SWOT
  • Exhibits230: Pfizer Inc. - Overview
  • Exhibits231: Pfizer Inc. - Product / Service
  • Exhibits232: Pfizer Inc. - Key news
  • Exhibits233: Pfizer Inc. - Key offerings
  • Exhibits234: SWOT
  • Exhibits235: Solco Healthcare - Overview
  • Exhibits236: Solco Healthcare - Product / Service
  • Exhibits237: Solco Healthcare - Key offerings
  • Exhibits238: SWOT
  • Exhibits239: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits240: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits241: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits242: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits243: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits244: SWOT
  • Exhibits245: Inclusions checklist
  • Exhibits246: Exclusions checklist
  • Exhibits247: Currency conversion rates for US$
  • Exhibits248: Research methodology
  • Exhibits249: Information sources
  • Exhibits250: Data validation
  • Exhibits251: Validation techniques employed for market sizing
  • Exhibits252: Data synthesis
  • Exhibits253: 360 degree market analysis
  • Exhibits254: List of abbreviations
目次
Product Code: IRTNTR40742

The alzheimers disease therapeutics market is forecasted to grow by USD 5,980.2 mn during 2024-2029, accelerating at a CAGR of 10.2% during the forecast period. The report on the alzheimers disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability, research, and development of novel biomarkers, increasing awareness of alzheimers disease, and strong pipeline coupled with approval of therapeutics.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20259.2%
CAGR10.2%
Incremental Value$5,980.2 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's alzheimers disease therapeutics market is segmented as below:

By Distribution Channel

    • Hospital pharmacy
    • Retail pharmacy
    • E-commerce pharmacy

By Drug Class

    • Cholinesterase inhibitors
    • N-methyl-D-aspartate receptor antagonist
    • Others

By Therapeutic Area

    • Symptomatic treatments
    • Disease-modifying therapies
    • Immunotherapies
    • Gene therapies
    • Small molecule inhibitors

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the emergence of regenerative therapies as one of the prime reasons driving the alzheimers disease therapeutics market growth during the next few years. Also, increasing funding for therapeutics discovery and availability of highly sensitive diagnostic modalities will lead to sizable demand in the market.

The report on the alzheimers disease therapeutics market covers the following areas:

    • Alzheimers Disease Therapeutics Market sizing
    • Alzheimers Disease Therapeutics Market forecast
    • Alzheimers Disease Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading alzheimers disease therapeutics market vendors that include AB Science SA, AbbVie Inc., AgeneBio Inc., Aurobindo Pharma Ltd., Biogen Inc., Cipla Inc., Curasia Medilab, Denali Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Grifols SA, H Lundbeck AS, Johnson and Johnson, Lifecare Neuro Products Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., Psycogen Captab, Solco Healthcare, and Teva Pharmaceutical Industries Ltd.. Also, the alzheimers disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Distribution Channel
    • Executive Summary - Chart on Market Segmentation by Drug Class
    • Executive Summary - Chart on Market Segmentation by Therapeutic Area
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Alzheimers Disease Therapeutics Market 2019 - 2023
    • Historic Market Size - Data Table on Global Alzheimers Disease Therapeutics Market 2019 - 2023 ($ million)
  • 5.2 Distribution Channel segment analysis 2019 - 2023
    • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
  • 5.3 Drug Class segment analysis 2019 - 2023
    • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • 5.4 Therapeutic Area segment analysis 2019 - 2023
    • Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Alzheimers Disease Therapeutics Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

  • 8.1 Market segments
    • Chart on Distribution Channel - Market share 2024-2029 (%)
    • Data Table on Distribution Channel - Market share 2024-2029 (%)
  • 8.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 8.3 Hospital pharmacy - Market size and forecast 2024-2029
    • Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • 8.4 Retail pharmacy - Market size and forecast 2024-2029
    • Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • 8.5 E-commerce pharmacy - Market size and forecast 2024-2029
    • Chart on E-commerce pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on E-commerce pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on E-commerce pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on E-commerce pharmacy - Year-over-year growth 2024-2029 (%)
  • 8.6 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Drug Class

  • 9.1 Market segments
    • Chart on Drug Class - Market share 2024-2029 (%)
    • Data Table on Drug Class - Market share 2024-2029 (%)
  • 9.2 Comparison by Drug Class
    • Chart on Comparison by Drug Class
    • Data Table on Comparison by Drug Class
  • 9.3 Cholinesterase inhibitors - Market size and forecast 2024-2029
    • Chart on Cholinesterase inhibitors - Market size and forecast 2024-2029 ($ million)
    • Data Table on Cholinesterase inhibitors - Market size and forecast 2024-2029 ($ million)
    • Chart on Cholinesterase inhibitors - Year-over-year growth 2024-2029 (%)
    • Data Table on Cholinesterase inhibitors - Year-over-year growth 2024-2029 (%)
  • 9.4 N-methyl-D-aspartate receptor antagonist - Market size and forecast 2024-2029
    • Chart on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2024-2029 ($ million)
    • Data Table on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2024-2029 ($ million)
    • Chart on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2024-2029 (%)
    • Data Table on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2024-2029 (%)
  • 9.5 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Drug Class
    • Market opportunity by Drug Class ($ million)
    • Data Table on Market opportunity by Drug Class ($ million)

10 Market Segmentation by Therapeutic Area

  • 10.1 Market segments
    • Chart on Therapeutic Area - Market share 2024-2029 (%)
    • Data Table on Therapeutic Area - Market share 2024-2029 (%)
  • 10.2 Comparison by Therapeutic Area
    • Chart on Comparison by Therapeutic Area
    • Data Table on Comparison by Therapeutic Area
  • 10.3 Symptomatic treatments - Market size and forecast 2024-2029
    • Chart on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
    • Data Table on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
    • Chart on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
    • Data Table on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
  • 10.4 Disease-modifying therapies - Market size and forecast 2024-2029
    • Chart on Disease-modifying therapies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Disease-modifying therapies - Market size and forecast 2024-2029 ($ million)
    • Chart on Disease-modifying therapies - Year-over-year growth 2024-2029 (%)
    • Data Table on Disease-modifying therapies - Year-over-year growth 2024-2029 (%)
  • 10.5 Immunotherapies - Market size and forecast 2024-2029
    • Chart on Immunotherapies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Immunotherapies - Market size and forecast 2024-2029 ($ million)
    • Chart on Immunotherapies - Year-over-year growth 2024-2029 (%)
    • Data Table on Immunotherapies - Year-over-year growth 2024-2029 (%)
  • 10.6 Gene therapies - Market size and forecast 2024-2029
    • Chart on Gene therapies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Gene therapies - Market size and forecast 2024-2029 ($ million)
    • Chart on Gene therapies - Year-over-year growth 2024-2029 (%)
    • Data Table on Gene therapies - Year-over-year growth 2024-2029 (%)
  • 10.7 Small molecule inhibitors - Market size and forecast 2024-2029
    • Chart on Small molecule inhibitors - Market size and forecast 2024-2029 ($ million)
    • Data Table on Small molecule inhibitors - Market size and forecast 2024-2029 ($ million)
    • Chart on Small molecule inhibitors - Year-over-year growth 2024-2029 (%)
    • Data Table on Small molecule inhibitors - Year-over-year growth 2024-2029 (%)
  • 10.8 Market opportunity by Therapeutic Area
    • Market opportunity by Therapeutic Area ($ million)
    • Data Table on Market opportunity by Therapeutic Area ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.9 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.10 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.11 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.12 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.13 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.14 Mexico - Market size and forecast 2024-2029
    • Chart on Mexico - Market size and forecast 2024-2029 ($ million)
    • Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
    • Chart on Mexico - Year-over-year growth 2024-2029 (%)
    • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
  • 12.15 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.16 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 AB Science SA
    • AB Science SA - Overview
    • AB Science SA - Product / Service
    • AB Science SA - Key offerings
    • SWOT
  • 15.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 15.6 AgeneBio Inc.
    • AgeneBio Inc. - Overview
    • AgeneBio Inc. - Product / Service
    • AgeneBio Inc. - Key offerings
    • SWOT
  • 15.7 Aurobindo Pharma Ltd.
    • Aurobindo Pharma Ltd. - Overview
    • Aurobindo Pharma Ltd. - Product / Service
    • Aurobindo Pharma Ltd. - Key offerings
    • SWOT
  • 15.8 Cipla Inc.
    • Cipla Inc. - Overview
    • Cipla Inc. - Business segments
    • Cipla Inc. - Key news
    • Cipla Inc. - Key offerings
    • Cipla Inc. - Segment focus
    • SWOT
  • 15.9 Eisai Co. Ltd.
    • Eisai Co. Ltd. - Overview
    • Eisai Co. Ltd. - Business segments
    • Eisai Co. Ltd. - Key offerings
    • Eisai Co. Ltd. - Segment focus
    • SWOT
  • 15.10 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 15.11 Grifols SA
    • Grifols SA - Overview
    • Grifols SA - Business segments
    • Grifols SA - Key news
    • Grifols SA - Key offerings
    • Grifols SA - Segment focus
    • SWOT
  • 15.12 H Lundbeck AS
    • H Lundbeck AS - Overview
    • H Lundbeck AS - Product / Service
    • H Lundbeck AS - Key offerings
    • SWOT
  • 15.13 Johnson and Johnson
    • Johnson and Johnson - Overview
    • Johnson and Johnson - Business segments
    • Johnson and Johnson - Key news
    • Johnson and Johnson - Key offerings
    • Johnson and Johnson - Segment focus
    • SWOT
  • 15.14 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
    • SWOT
  • 15.15 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 15.16 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.17 Solco Healthcare
    • Solco Healthcare - Overview
    • Solco Healthcare - Product / Service
    • Solco Healthcare - Key offerings
    • SWOT
  • 15.18 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations